par Lalami, Yassine 
;Awada, Ahmad
Référence Current opinion in oncology, 23, 3, page (235-240)
Publication Publié, 2011-05
;Awada, Ahmad Référence Current opinion in oncology, 23, 3, page (235-240)
Publication Publié, 2011-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Lalami, Yassine; Awada, Ahmad |
| Informations sur la publication: | Current opinion in oncology, 23, 3, page (235-240) |
| Statut de publication: | Publié, 2011-05 |
| Sujet CREF: | Cancérologie |
| Mots-clés: | molecular-targeted therapies |
| multitargeted kinase inhibitors | |
| recurrent disease | |
| thyroid cancer | |
| MeSH keywords: | Angiogenesis Inhibitors -- pharmacology -- therapeutic use |
| Antineoplastic Agents -- pharmacology -- therapeutic use | |
| Clinical Trials, Phase III as Topic | |
| Humans | |
| Molecular Targeted Therapy -- methods | |
| Neoplasm Recurrence, Local -- drug therapy -- genetics -- metabolism | |
| Protein Kinase Inhibitors -- pharmacology -- therapeutic use | |
| Randomized Controlled Trials as Topic | |
| Thyroid Neoplasms -- drug therapy -- genetics -- metabolism | |
| Note générale: | Journal Article |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8746 |
| info:doi/10.1097/CCO.0b013e3283448206 | |
| info:scp/79954998796 | |
| info:pmid/21330922 |
